Cargando…
Molecular Diagnostics of Mucormycosis in Hematological Patients: A Literature Review
Objectives: to analyze the results of molecular methods applying for the diagnosis of mucormycosis in hematologic patients based on a literature review. Data sources: A systematic search in databases PubMed, Google Scholar for August 2019. Review eligibility criteria: original articles published in...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958327/ https://www.ncbi.nlm.nih.gov/pubmed/31795369 http://dx.doi.org/10.3390/jof5040112 |
_version_ | 1783487388009365504 |
---|---|
author | Shadrivova, Olga V. Burygina, Ekaterina V. Klimko, Nikolai N. |
author_facet | Shadrivova, Olga V. Burygina, Ekaterina V. Klimko, Nikolai N. |
author_sort | Shadrivova, Olga V. |
collection | PubMed |
description | Objectives: to analyze the results of molecular methods applying for the diagnosis of mucormycosis in hematologic patients based on a literature review. Data sources: A systematic search in databases PubMed, Google Scholar for August 2019. Review eligibility criteria: original articles published in English, studies of molecular methods for the diagnosis of mucormycosis in hematologic patients. Results. We analyzed the research data from 116 hematological patients with mucormycosis, including children (6%). Patients with localized forms of mucormycosis prevailed (72%), and lung involvement was diagnosed in 58% of these cases. For molecular verification of the causative agent of mucormycosis, blood serum was most often used, less commonly postoperative and autopsy material, biopsy specimens, formalin-fixed paraffin-embedded samples and bronchoalveolar lavage, pleural fluid and sputum. The sensitivity of molecular diagnostics of mucormycosis in a cohort of hematological patients was 88.2%. Conclusion. The use of molecular techniques along with standard mycological methods will improve the diagnostics of mucormycosis in hematologic patients. However, prospective studies of the effectiveness of molecular methods for the diagnosis of mucormycosis of various etiologies in hematological patients, including children, using bronchoalveolar lavage (BAL) and cerebrospinal fluid (CSF) are needed. |
format | Online Article Text |
id | pubmed-6958327 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-69583272020-01-23 Molecular Diagnostics of Mucormycosis in Hematological Patients: A Literature Review Shadrivova, Olga V. Burygina, Ekaterina V. Klimko, Nikolai N. J Fungi (Basel) Review Objectives: to analyze the results of molecular methods applying for the diagnosis of mucormycosis in hematologic patients based on a literature review. Data sources: A systematic search in databases PubMed, Google Scholar for August 2019. Review eligibility criteria: original articles published in English, studies of molecular methods for the diagnosis of mucormycosis in hematologic patients. Results. We analyzed the research data from 116 hematological patients with mucormycosis, including children (6%). Patients with localized forms of mucormycosis prevailed (72%), and lung involvement was diagnosed in 58% of these cases. For molecular verification of the causative agent of mucormycosis, blood serum was most often used, less commonly postoperative and autopsy material, biopsy specimens, formalin-fixed paraffin-embedded samples and bronchoalveolar lavage, pleural fluid and sputum. The sensitivity of molecular diagnostics of mucormycosis in a cohort of hematological patients was 88.2%. Conclusion. The use of molecular techniques along with standard mycological methods will improve the diagnostics of mucormycosis in hematologic patients. However, prospective studies of the effectiveness of molecular methods for the diagnosis of mucormycosis of various etiologies in hematological patients, including children, using bronchoalveolar lavage (BAL) and cerebrospinal fluid (CSF) are needed. MDPI 2019-11-29 /pmc/articles/PMC6958327/ /pubmed/31795369 http://dx.doi.org/10.3390/jof5040112 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Shadrivova, Olga V. Burygina, Ekaterina V. Klimko, Nikolai N. Molecular Diagnostics of Mucormycosis in Hematological Patients: A Literature Review |
title | Molecular Diagnostics of Mucormycosis in Hematological Patients: A Literature Review |
title_full | Molecular Diagnostics of Mucormycosis in Hematological Patients: A Literature Review |
title_fullStr | Molecular Diagnostics of Mucormycosis in Hematological Patients: A Literature Review |
title_full_unstemmed | Molecular Diagnostics of Mucormycosis in Hematological Patients: A Literature Review |
title_short | Molecular Diagnostics of Mucormycosis in Hematological Patients: A Literature Review |
title_sort | molecular diagnostics of mucormycosis in hematological patients: a literature review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958327/ https://www.ncbi.nlm.nih.gov/pubmed/31795369 http://dx.doi.org/10.3390/jof5040112 |
work_keys_str_mv | AT shadrivovaolgav moleculardiagnosticsofmucormycosisinhematologicalpatientsaliteraturereview AT buryginaekaterinav moleculardiagnosticsofmucormycosisinhematologicalpatientsaliteraturereview AT klimkonikolain moleculardiagnosticsofmucormycosisinhematologicalpatientsaliteraturereview |